Corona Remedies

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE02ZQ01018
  • NSEID: CORONA
  • BSEID: 544644
INR
1,374.30
7.9 (0.58%)
BSENSE

Dec 19

BSE+NSE Vol: 6.49 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

6.49 lacs (-84.27%) Volume

Shareholding (Dec 2025)

FII

1.04%

Held by 43 FIIs

DII

0.89%

Held by 16 DIIs

Promoter

69.00%

Which are the latest news on Corona Remedies?

19-Dec-2025
No latest news for Corona Remedies found.

Why is Corona Remedies falling/rising?

20-Dec-2025

As of 19-Dec, the stock price of Corona Remedies Ltd is rising to 1,374.85, indicating a potential trend reversal after previous declines. However, it remains below key moving averages and has seen a significant drop in investor participation, suggesting challenges ahead.

As of 19-Dec, the stock price of Corona Remedies Ltd is rising, currently at 1,374.85, reflecting an increase of 12.95 (0.95%). This upward movement comes after two consecutive days of decline, indicating a potential trend reversal. Additionally, the stock reached an intraday high of Rs 1,437.95, which is a significant increase of 5.58% during the trading day. <BR><BR>However, it is important to note that despite this rise, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a longer-term downward trend. Furthermore, investor participation has decreased significantly, with delivery volume dropping by 85.03% compared to the 5-day average, indicating reduced interest from investors. <BR><BR>Overall, while the stock is experiencing a rise in price today, the broader context shows challenges such as lower trading volumes and being below key moving averages, which could affect its future performance.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 8,683 Cr (Mid Cap)

stock-summary
P/E

56.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.01

stock-summary
Return on Equity

24.58%

stock-summary
Price to Book

13.74

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
0.38
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
4.68%
ROCE (avg)
29.97%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
56
Industry P/E
33
Price to Book Value
13.87
EV to EBIT
41.43
EV to EBITDA
35.01
EV to Capital Employed
14.01
EV to Sales
7.02
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
33.82%
ROE (Latest)
24.58%
Technicals key factors
Indicator
Weekly
Monthly
Icon
No records
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 14 Schemes (2.44%)

FIIs

Held by 43 FIIs (1.04%)

Promoter with highest holding

Ankurbhai K Mehta (22.0%)

Highest Public shareholder

Sepia Investments Limited (19.76%)

Individual Investors Holdings

4.83%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Corona Remedies"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Corona Remedies"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Corona Remedies"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Corona Remedies"
  }
]
stock-summaryCompany CV
About Corona Remedies Ltd stock-summary
stock-summary
Corona Remedies Ltd
Mid Cap
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available